KEEPING YOU UP TO DATEClearstate Healthcare InsightsClearstate Insights is your single source to all our latest healthcare intelligence. From recently published reports offering thought-provoking analysis, to information about new products and services, we will ensure you are always kept informed. Sign up to Clearstate’s newsletter
Q2 2022 IVD China: point-of-care infectious-disease testing outperforms during the latest covid surge The impact of China’s latest covid-19 surge heads the… Centralised Diagnostics (CEDx) | Covid-19 testing | In-vitro diagnostics | Infectious Diseases Testing Monitor | Molecular Diagnostics (MDx) | Asia | Centralised Diagnostics (CEDx) | Covid-19 testing | IVD Gateway | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Tissue Diagnostics (TDx)
Insights into Europe’s covid-19 testing and technology use 2021-2022: PCR v serology v antigen Europe is shifting its covid-19-approach from pandemic to… Centralised Diagnostics (CEDx) | Covid-19 testing | In-vitro diagnostics | Molecular Diagnostics (MDx) | Europe | IVD Gateway | Molecular Diagnostics (MDx)
Watch on-demand: Will Covid-19 Accelerate the Next Wave of Adoption of Next-Generation Sequencing (NGS) in Healthcare? Now, sequencing looks set to become even more integral in… Covid-19 testing | In-vitro diagnostics | Next Generation Sequencing (NGS) | Uncategorised | Global | IVD Gateway | Next Generation Sequencing (NGS)
Rapid antigen tests to erode PCR-based molecular covid test market in APAC Emergent covid-19 screening technologies coupled with… Covid-19 testing | Molecular Diagnostics (MDx) | Asia | IVD Gateway | Molecular Diagnostics (MDx)
Covid-19: Molecular testing capacity expands in Asia-Pacific Molecular diagnostics (MDx) testing capacities and… Covid-19 testing | In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | IVD Gateway | Molecular Diagnostics (MDx)
Covid-19: accelerating digitalisation of surgical platforms and solutions The covid-19 pandemic has accelerated the rise of telehealth… Covid-19 testing | General surgery | Global | Surgical Gateway
Keeping ahead of infectious diseases in Asia-Pacific with increased testing Our new briefing paper looks at the testing trends in… Covid-19 testing | In-vitro diagnostics | Infectious Diseases Testing Monitor | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Asia | IVD Gateway | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Point-of-care testing (POCT)
[On-demand Webinar] Covid-19 Impact: Molecular Diagnostic (MDx) Market EIU Healthcare zooms in on two of the fastest-growing… Covid-19 testing | In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | Europe | Global | IVD Gateway | Molecular Diagnostics (MDx)
[On-demand Webinar] Will Covid-19 Accelerate the Next Wave of Adoption of Next-Generation Sequencing (NGS) in Healthcare? EIU Healthcare hosted the “Will Covid-19 Accelerate the… Covid-19 testing | In-vitro diagnostics | Next Generation Sequencing (NGS) | Asia | IVD Gateway
Covid-19 Testing Monitor: More than Seven-fold Increase in Diagnostic Testing Volume in the US, Brazil and India EIU Healthcare has launched the Covid-19 Testing Monitor –… Covid-19 testing | In-vitro diagnostics | Americas | Asia | Europe | Global | IVD Gateway
Surgical access and the Covid-19 capacity crunch In this report on “Playing catch-up: surgical access and… Covid-19 testing | General surgery | In-vitro diagnostics | Surgical device and IVD | Americas | Asia | Surgical Gateway
European IVD Market: Pre- and Post-Covid-19 In our white paper “The European IVD Market Landscape… Covid-19 testing | In-vitro diagnostics | Europe | IVD Gateway
Sign up to our free newsletterThe latest trends and insights into the IVD and Surgical sectors, from our specialists and analysts, delivered directly to your inbox. Sign up to Clearstate’s newsletter today. Sign up now